Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery

• Status: Recruiting
• Trial end date: 2021-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To study analgesic efficacy &safety of bilateral erector spinae block for upper abdominal cancer surgery as apart of multimodal analgesia.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: South Egypt Cancer Institute
• Treatments: Levobupivacaine

Criteria

Inclusion Criteria:

• Patient subjected to major upper abdominal cancer surgery.

• The enrolled age will be from 18-70 years old.

• ASA: I-III, NYHA: I-III.

Exclusion Criteria:

• ASA & physical status (NYHA) > III.

• Pregnant women.

• Body mass index >40 kg/m2.

• Pre-operative opioid consumption.

• Contraindication or patient's refusal of the procedure.

• Un co-operative patient.

• Coagulopathy, skin infection, significant organ dysfunction or drug allergy.